The EU Commission conditionally clears a merger in the pharmaceutical sector creating the largest pharmaceutical company in the world in terms of sales and R&D spending (Pfizer / Pharmacia)

"Merger Control: Main developments between 1st January 2003 and 30th April 2003"* The European Commission authorised, subject to conditions, the acquisition of Pharmacia Corporation (Pharmacia) by Pfizer Inc. (Pfizer) in a deal creating the largest pharmaceutical company in the world in terms of sales and R&D spending. The two companies’ activities were considered to be largely complementary. However the operation gave rise to a number of horizontal overlaps in human pharmaceuticals (including existing and pipeline products) and animal healthcare. The approval followed an investigation into a number of treatment areas both in human pharmaceuticals and in animal healthcare, where the transaction raised serious doubts as to the compatibility with the common market. In reaction to

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • DG Economic and Financial Affairs (ECFIN) (Brussels)

Quotation

Kay Parplies, The EU Commission conditionally clears a merger in the pharmaceutical sector creating the largest pharmaceutical company in the world in terms of sales and R&D spending (Pfizer / Pharmacia), 27 February 2003, e-Competitions Cooperation between National Competition Authorities, Art. N° 38904

Visites 393

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues